As of June 19, 2025, BiondVax Pharmaceuticals Ltd (BVXV) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing BiondVax Pharmaceuticals Ltd's Forward P/E to Peers
To better understand BiondVax Pharmaceuticals Ltd's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| BiondVax Pharmaceuticals Ltd (BVXV) | - |
| Teva Pharmaceutical Industries Ltd (TEVA.TA) | 303.20 |
Compared to its competitors, BiondVax Pharmaceuticals Ltd's Forward P/E is difficult to compare due to insufficient data.